Presentations

From dog to human: precision medicine for comparative oncology

January 21, 2020

Presentation Detail

  • Speaker: Sungwon Lim, PhD, CEO & Co-Founder of ImpriMed, Inc.
  • Date: January 21, 2020
  • Description: ‍ImpriMed develops functional precision medicine technologies to help veterinary oncologists find out the most effective treatment options for individual cancer patients by building up a patient-derived database for pet cancer treatment, which can be eventually translated into human cancer care.

Presentations

Presentations
VCS Logo

Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics

Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
VCS Logo

Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning

Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
VCS Logo

Decoding Feline Lymphoma: From Diagnosis to Prognosis

Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
SAVY Logo

Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models

Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Learn More →
Presentations
WVCC logo

Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support

World Veterinary Cancer Congress 2024
Learn More →
Presentations
WVCC Logo

Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results

World Veterinary Cancer Congress 2024
Learn More →
Presentations
PMWC 2024

AI-driven Personalized Medicine for Cancer Care

Precision Medicine World Conference 2024
Learn More →
Presentations
Veterinary Cancer Society Logo

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society Logo

Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society logo

Impact of AI on clinical practice and outcome

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society Logo

Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care

Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Learn More →
Presentations
Precision Medicine World Conference logo

Reinventing precision medicine: from dogs to humans

Precision Medicine World Conference 2023
Learn More →
Presentations
Veterinary Cancer Society Logo

Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS

Veterinary Cancer Society Annual Conference 2022
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed Research Update

Veterinary Cancer Society Annual Conference 2022
Learn More →
Presentations
Veterinary Cancer Society Logo

Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma

Veterinary Cancer Society Mid-Year Conference 2022
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed Research Update

Veterinary Cancer Society Mid-Year Conference 2022
Learn More →
Presentations
Animal Health, Nutrition and Technology Innovation Europe logo

Precision medicine for pet cancer care

Animal Health, Nutrition and Technology Innovation Europe 2022
Learn More →
Presentations
Veterinary Cancer Society Logo

Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model

Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Veterinary Cancer Society Logo

ImpriMed: Experiences from the eyes of an oncologist in clinical practice

Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Veterinary Cancer Society Logo

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

Veterinary Cancer Society Annual Conference 2020
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients

Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
World Veterinary Cancer Congress logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

World Veterinary Cancer Congress 2020
Learn More →
Presentations
NYC Oncology Conference 2019

ImpriMed: precision medicine for pet cancer care

NYC Oncology Conference 2019
Learn More →
Presentations
Veterinary Cancer Society Logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

Veterinary Cancer Society Annual Conference 2019
Learn More →